Doug Hampton STOCKHOLM, May 16, 2023 /PRNewswire/ — Strong eGFR Data from Positive NefIgArd Phase 3 Trial Readout “In March we announced that the global NefIgArd Phase 3 trial successfully met its primary endpoint, estimated glomerular filtration rate (eGFR), with a p value < 0.0001. Achieving this clinically relevant endpoint of kidney filtration capability represents a crowning … Read more
STOCKHOLM, May 16, 2023 /PRNewswire/ — Strong eGFR Data from Positive NefIgArd Phase 3 Trial Readout “In March we announced that the global NefIgArd Phase 3 trial successfully met its primary endpoint, estimated glomerular filtration rate (eGFR), with a p value < 0.0001. Achieving this clinically relevant endpoint of kidney filtration capability represents a crowning … Read more
Accelerating Research and Development, and Access and Delivery for NTDs TOKYO, May 16, 2023 /PRNewswire/ — On May 12th, the eve of the G7 Health Ministers’ Meeting, global health leaders from around the world convened in Nagasaki to call for the prioritization of neglected tropical diseases (NTDs). Gathering at the Symposium for G7 Health Ministers’ … Read more
the essential A pharmacy in the center provides a teleconsultation terminal. An alternative solution in case of difficulties to make an appointment quickly. The Villefranchois know it, it is not always easy to make an emergency appointment with your doctor. According to a study on health in rural areas, presented at the Congress of Rural … Read more
the essential At the end of a public meeting, about fifty representatives of the Aude Federation of the Communist Party went in procession in front of the buildings of the ARS and the prefecture, in Carcassonne, to read there the “declaration of state emergency” forwarded to these two institutions. Meeting requests are also made. If … Read more
Recently, Magnoac santé, in the presence of members of the board of directors, liberal health professionals, institutional partners, the management team and caregivers of the SSIAD, users and carers, through Myriam Cazes-Recurt opened this AGM 2023. First-rate reminder with the value of the SSIAD, a medico-social service for nearly 39 years to date and there … Read more
Mobility circuits, and informative stands for parents… This is what made up the multipurpose room at Garros, in Auch, last week to raise awareness of the fight against screens from an early age. Several professionals were present, the CAF, the PMI, the Social and Cultural Center, the CPAM… to discuss with parents. At the same … Read more
STOCKHOLM, May 16, 2023 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Health Canada has accepted a New Drug Submission (NDS) for lecanemab (brand name in the U.S.: LEQEMBI™), an investigational anti-amyloid beta (Aβ) protofibril[1] antibody, for the treatment of early Alzheimer’s disease[2] with confirmed amyloid pathology in the brain. … Read more
STOCKHOLM, May 16, 2023 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Health Canada has accepted a New Drug Submission (NDS) for lecanemab (brand name in the U.S.: LEQEMBI™), an investigational anti-amyloid beta (Aβ) protofibril[1] antibody, for the treatment of early Alzheimer’s disease[2] with confirmed amyloid pathology in the brain. … Read more
STOCKHOLM, May 16, 2023 /PRNewswire/ — SciBase Holding AB (“SciBase”) (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders hereby clarifies the May 15th announcement that Simon Grant will leave his position as CEO for personal reasons. Simon will transition out of his role over the next six months but will remain formally … Read more